Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3α by protease-activated receptors (PARs) in human gingival epithelial cells

Innate Immunity

Volumn 16, Issue 2, 2010, Pages 104-114

  Rohani, Maryam G ^a   Beyer, Richard P ^a   Hacker, Beth M ^a   Dommisch, Henrik ^a,b   Dale, Beverly A ^a   Chung, Whasun O ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Innate immunity; Oral keratinocytes; Protease activated receptors

Indexed keywords

EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; THROMBIN; TRYPSIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GINGIVA; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION;

ANTIBODIES, BLOCKING; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL20; CHEMOKINE CXCL5; EPITHELIAL CELLS; GINGIVA; HUMANS; IMMUNITY, INNATE; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RNA, SMALL INTERFERING; THROMBIN; TRYPSIN;

PORPHYROMONAS GINGIVALIS;

EID: 77952326080     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425909339233     Document Type: Article

References (44)

1. Sugawara Y, Uehara A, Fujimoto Y et al. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 2006; 85: 524-529. (Pubitemid 43945490)
2. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068.
3. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609-613.
4. Coughlin SR. Protease-activated receptors in hemostasia, thrombosis and vascular biology. J Thromb Haemost 2005; 3: 1800-1814.
5. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001; 53: 245-282.
6. Steinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinaseactivated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005; 26: 1-43. (Pubitemid 40209385)
7. Coughlin SR, Camerer E. PARticipation in inflammation. J Clin Invest 2003; 111; 25-27.
8. MacNaughton WK. Epithelial effects of proteinase-activated receptors in the gastrointestinal tract. Mem Inst Oswaldo Cruz 2005;100:211-215. (Pubitemid 40685466)
9. Lourbakos A, Potempa J, Travis J et al. Arginine-specific protease from. Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin6 secretion. Infect Immun 2001; 69: 5121-5130. (Pubitemid 32674499)
10. Chung WO, Hansen SR, Rao D, Dale BA. Protease-activated receptor signaling increases epithelial antimicrobial peptide expression. J Immunol 2004; 173: 5165-5170. (Pubitemid 39387799)
11. Dommisch H, Chung WO, Rohani MG et al. Protease-activated receptor 2 mediates human beta-defensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis. Infect Immun 2007; 75: 4326-4333. (Pubitemid 47378089)
12. Uehara A, Sugawara S, Muramoto K, Takada H. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J Immunol 2002; 169: 4594-4603. (Pubitemid 35178239)
13. Uehara A, Muramoto K, Takada H, Sugawara S. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 2003; 170: 5690-5696. (Pubitemid 36621425)
14. Holzhausen M, Spolidorio LC, Vergnolle N. Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats. / Dent Res 2005; 84: 154-159. (Pubitemid 43822048)
15. Fiorucci S, Mencarelli A, Palazzetti B et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA 2001; 98: 13936-13941.
16. Tatakis DN. Blood coagulation factors in periodontal pathophysiology: a review with emphasis on the role of thrombin. Semin Thromb Hemost 1992; 18: 28-33.
17. Imamura T, Banbula A, Pereira PJ, Travis J, Potempa J. Activation of human prothrombin by arginine-specific cysteine proteinases (Gingipains R) from Porphyromonas gingivalis. J Biol Chem 2001; 276: 18984-18991.
18. Eley BM, Cox SW. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: a comparison of levels before and after periodontal surgery in chronic periodontitis patients. J Periodontal 1992; 63: 412-417.
19. Chung WO, Dale BA. Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun 2004; 72: 352-358.
20. Gentleman RC, Carey VJ, Bates DM et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
21. Wu Z, Irizarry R, Gentleman RC, Murillo FM, Spencer F. A model based background adjustment for oligonucleotide expression arrays, J Am Stat Assoc 2004; 99: 909-917. (Pubitemid 39665934)
22. Al-Shahrour F, Minguez P, Tarraga J et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res 2006; 34: W472-W476. (Pubitemid 44529816)
23. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
24. Brodersen DE, Nissen P. The social life of ribosomal proteins. FEBS J 2005; 272: 2098-2108.
25. Wool IG. Extraribosomal functions of ribosomal proteins. Trends Biochem Sci 1996; 21: 164-165.
26. Hofman P, Butori C, Havet K et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. Br J Cancer 2008; 98: 956-964. (Pubitemid 351341605)
27. Kon S, Ikesue M, Kimura C et al. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin. J Exp Med 2008; 205: 25-33.
28. O'Brien PJ, Prevost N, Molino M et al. Thrombin responses in human endothelial cells. Contributions from receptors other than PARI include the transactivation of PAR2 by thrombin-cleaved PARI, J Biol Chem 2000; 275: 13502-13509. (Pubitemid 30257415)
29. Derian CK, Eckardt AJ, Andrade-Gordon P. Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors. Cell Growth Differ 1997; 8: 743-749. (Pubitemid 27287805)
30. Algermissen B, Sitzmann J, Nurnberg W, Laubscher JC, Henz BM, Bauer F. Distribution and potential biologic function of the thrombin receptor PAR-I on human keratinocytes. Arch Dermatol Res 2000; 292: 488-495. (Pubitemid 32112806)
31. Fager G. Thrombin and proliferation of vascular smooth muscle cells. Circ Res 1995; 77: 645-650.
32. Moller T, Hanisch UK, Ransom. BR. Thrombin-induced activation of cultured rodent microglia. J Neurochem 2000; 75: 1539-1547.
33. Ahmad R, Knafo L, Xu J, Sindhu ST, Menezes J, Ahmad A. Thrombin induces apoptosis in human tumor cells. Int J Cancer 2000; 87: 707-715. (Pubitemid 30620414)
34. Kaufmann K, Thiel G. Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Eg.r-1, a zinc finger transcriptional regulator. J Cell Biochem 2002; 85: 381-391. (Pubitemid 34274905)
35. Kim, TH, Xiong H, Zhang Z, Ren B. beta-Catenin activates the growth factor endothelin-1 in colon cancer cells. Oncogene 2005; 24: 597-604. (Pubitemid 40188564)
36. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med 1991; 174: 1355-1362.
37. + CXC chemokine expression in benign and malignant colorectal conditions. BMC Cancer 2008; 8: 178-188.
38. Park JY, Park KH, Bang S et al. CXCL5 overexpression is associated with, late stage gastric cancer. J Cancer Res Clin Oncol 2007; .133: 835-840. (Pubitemid 350218909)
39. Starner TD, Barker CK, Jia HP, Rang Y, McCray Jr, PB. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 2003; 29:627-633.
40. Yang D, Chen Q, Hoover DM et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003; 74: 448-455. (Pubitemid 38040406)
41. Yin L, Dale BA. Activation of protective responses in oral epithelial cells by Fusobacterium nucleatum and human betadefensin-2. J Med Microbiol 2007; 56: 976-987. (Pubitemid 47047493)
42. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003; 4: .117-124.
43. McLaughlin JN, Patterson MM, Malik AB. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA 2007; 104: 5662-5667.
44. Ostrowska E, Reiser G. The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release. Cell Mol Life Sci 2008; 65: 970-981.